Contemporary management of ST-segment elevation myocardial infarction

@article{Yadlapati2016ContemporaryMO,
  title={Contemporary management of ST-segment elevation myocardial infarction},
  author={Ajay Yadlapati and Mark M. Gajjar and Daniel R. Schimmel and Mark J Ricciardi and James D Flaherty},
  journal={Internal and Emergency Medicine},
  year={2016},
  volume={11},
  pages={1107-1113}
}
ST-elevation myocardial infarction (STEMI), which constitutes nearly 25–40 % of current acute myocardial infarction (AMI) cases, is a medical emergency that requires prompt recognition and treatment. Since the 2013 STEMI practice guidelines, a wealth of additional data that may further advance optimal STEMI practices has emerged. These data highlight the importance of improving patient treatment and transport algorithms for STEMI from non-primary percutaneous coronary intervention (PCI) centers… 
3 Citations

ST-segment elevation myocardial infarction with non-chest pain presentation at the Emergency Department: Insights from the Singapore Myocardial Infarction Registry

Patients who presented with a non-chest pain (NCP) STEMI had a distinct clinical profile and experienced poorer outcomes and Routine triage ECG could be considered for patients with high-risk factors and non-classical symptoms.

References

SHOWING 1-10 OF 60 REFERENCES

Emerging evidence that radial is safer than femoral percutaneous coronary intervention in subjects with ST segment elevation myocardial infarction.

Two recent trials support the systematic adoption of TRA instead of TFA approach to improve the clinical outcome of STEMI patients and put them in the context of previous scientific evidences collected in this field.

Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

The results suggest that a successful implementation of efforts to reduce DTB time has not resulted in the expected survival benefit and that in-hospital mortality was unchanged over the study period.

Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold

The findings suggest that implantation of BVS in STEMI patients is feasible in this small cohort of highly selected patients, and further evaluation in randomized-controlled trials is needed.

ST-segment elevation myocardial infarction – ideal scenario for bioresorbable vascular scaffold implantation?

The potential advantages of BVS implantation in STEMI patients, together with the most recent evidence from clinical studies, are discussed, highlighting safety and procedural concerns.

Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry

The choice of radial access site in patients with STEMI treated with primary PCI is associated with lower local bleeding complications like puncture site hematomas and is an independent predictor of fewer bleedings.

Nationwide Analysis of Patients With ST-Segment–Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program

More than one third of US STEMI patients transferred for primary PCI fail to achieve first door-to-device time ⩽120 minutes, despite estimated transfer times <60 minutes, which is related to process variables, comorbidities, and lower annual PCI hospital STEMI volumes.
...